Dr. David Fajgenbaum

We're just using the things that are already out there.

But I think that

proving out the impact of what we're doing and using AI to focus us in on the right opportunities, I think is important.

And then as we help more and more people, I hope that that'll lead to more support, whether it's from individuals who care about someone with a horrible disease or whether it's philanthropists or the federal government, I hope it's going to lead to more opportunities here.

Because like I said earlier, I'm alive because of a drug that wasn't made for my disease.

And there's a lot of people suffering today that could benefit from a drug we already have.

Where do people donate?

So you can go to everycreditor.org slash donate, and you can donate online.

We're a nonprofit organization, and we put every one of these dollars towards making sure that the drugs we have help the people who can benefit.

Thank you.

Sure.

So I shared a little bit about, maybe I'll share a couple of these patients.

So one of them is Michael.

He was diagnosed with a horrible form of cancer.

called metastatic angiosarcoma and that's where basically this cancer is in multiple places in your body and no one lives past a year with metastatic angiosarcoma.

This is 2016 and

We found a study from 2013.

It was just a laboratory study.

It wasn't done in patients in clinical trials by any means.

It was a lab study.